Ho TCS, Chan AHY, Ganesan A. Thirty years of HDAC inhibitors: 2020 insight and hindsight. J Med Chem. 2020;63:12460–84. https://doi.org/10.1021/acs.jmedchem.0c00830.

Article  CAS  PubMed  Google Scholar 

Cheng B, Pan W, Xiao Y, Ding Z, Zhou Y, Fei X, et al. HDAC-targeting epigenetic modulators for cancer immunotherapy. Eur J Med Chem. 2024;265:116129 https://doi.org/10.1016/j.ejmech.2024.116129.

Article  CAS  PubMed  Google Scholar 

Chen IC, Sethy B, Liou JP. Recent update of HDAC inhibitors in lymphoma. Front Cell Dev Biol. 2020;8:576391 https://doi.org/10.3389/fcell.2020.576391.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, Waschke BC, Woolaver RA, Chen SMY, Chen Z, Wang JH. HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma. Protein Cell. 2020;11:472–82. https://doi.org/10.1007/s13238-020-00694-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Chu H, Wang A, Yin H, Gao Y, Liu S, et al. Discovery of 2,5-diphenyl-1,3,4-thiadiazole derivatives as HDAC inhibitors with DNA binding affinity. Eur J Med Chem. 2022;241:114634 https://doi.org/10.1016/j.ejmech.2022.114634.

Article  CAS  PubMed  Google Scholar 

Zhang W-X, Huang J, Tian X-Y, Liu Y-H, Jia M-Q, Wang W, et al. A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy. Eur J Med Chem. 2023;259:115673 https://doi.org/10.1016/j.ejmech.2023.115673.

Article  CAS  PubMed  Google Scholar 

Biersack B, Polat S, Höpfner M. Anticancer properties of chimeric HDAC and kinase inhibitors. Semin Cancer Biol. 2022;83:472–86. https://doi.org/10.1016/j.semcancer.2020.11.005.

Article  CAS  PubMed  Google Scholar 

Sun L, Han L, Zhang L, Chen C, Zheng C. Design, synthesis, and antitumor activity evaluation of carbazole derivatives with potent HDAC inhibitory activity. Med Chem Res. 2023;32:1677–89. https://doi.org/10.1007/s00044-023-03084-0.

Article  CAS  Google Scholar 

Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol. 2007;25:84–90. https://doi.org/10.1038/nbt1272.

Article  CAS  PubMed  Google Scholar 

Finn PW, Loza E, Carstensen E. The discovery and development of belinostat. Success Drug Discov. 2016;2:31–57. https://doi.org/10.1002/9783527800315.ch3.

Article  CAS  Google Scholar 

Atadja P, Perez L. Discovery and development of Farydak (NVP‐LBH589, Panobinostat) as an anticancer drug. Success Drug Discov. 2016;2:59–88. https://doi.org/10.1002/9783527800315.ch4.

Article  CAS  Google Scholar 

Ning ZQ, Li ZB, Newman MJ, Shan S, Wang XH, Pan DS, et al. Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity. Cancer Chemoth Pharm. 2012;69:901–9. https://doi.org/10.1007/s00280-011-1766-x.

Article  CAS  Google Scholar 

Ganesan A. Romidepsin and the Zinc‐binding thiol family of natural product HDAC inhibitors. Success Drug Discov. 2016;2:13–29. https://doi.org/10.1002/9783527800315.ch2.

Article  CAS  Google Scholar 

Panja S, Ghosh K. Progress in benzimidazole/benzimidazolium-derived supramolecular gelators in ion recognition. Mini Rev Org Chem. 2020;17:1042–55. https://doi.org/10.2174/1570193X17999200430090415.

Article  CAS  Google Scholar 

Kumar R, Singh C, Mazumder A, Salahuddin, Abdullah MM, Kumar V, et al. Synthetic approach to potential anticancer benzimidazole derivatives: a review. Mini Rev Med Chem. 2022;22:1289–304. https://doi.org/10.2174/1389557521666211001122118.

Article  CAS  PubMed  Google Scholar 

Garuti L, Roberti M, Bottegoni G. Benzimidazole derivatives as kinase inhibitors. Curr Med Chem. 2014;21:2284–98. https://doi.org/10.2174/0929867321666140217105714.

Article  CAS  PubMed  Google Scholar 

Ganie AM, Dar AM, Khan FA, Dar BA. Benzimidazole derivatives as potential antimicrobial and antiulcer agents: a mini review. Mini Rev Med Chem 2019;19:1292–7. https://doi.org/10.2174/1381612824666181017102930.

Article  CAS  PubMed  Google Scholar 

Faydalı N, Arpacı ÖT. Benzimidazole and benzoxazole derivatives against Alzheimer’s disease. Chem Biodivers. 2024:e202400123. https://doi.org/10.1002/cbdv.202400123.

Vandyshev DY, Kovygin YA, Khmelevskaya TN, Sherbakov KA, Shikhalieva KD, Smoliannikova MY, et al. Synthesis of 3, 4-dihydropyrimido [1, 2-a] benzimidazoles, promising CRF1 receptor antagonists. Russ Chem Bull. 2024;73:994–1004. https://doi.org/10.1007/s11172-024-4213-y.

Article  CAS  Google Scholar 

Garcia CV, Nudelman NS, Steppe M, Schapoval EE. Structural elucidation of rabeprazole sodium photodegradation products. J Pharm Biomed Anal. 2008;46:88–93. https://doi.org/10.1016/j.jpba.2007.09.002.

Article  CAS  PubMed  Google Scholar 

Bali A, Bansal Y, Sugumaran M, Saggu JS, Balakumar P, Kaur G, et al. Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists. Bioorg Med Chem Lett. 2005;15:3962–5. https://doi.org/10.1016/j.bmcl.2005.05.054.

Article  CAS  PubMed  Google Scholar 

Chassaing C, Berger M, Heckeroth A, Ilg T, Jaeger M, Kern C, et al. Highly water-soluble prodrugs of anthelmintic benzimidazole carbamates: synthesis, pharmacodynamics, and pharmacokinetics. J Med Chem. 2008;51:1111–4. https://doi.org/10.1021/jm701456r.

Article  CAS  PubMed  Google Scholar 

Venugopal S, Kaur B, Verma A, Wadhwa P, Magan M, Hudda S, et al. Recent advances of benzimidazole as anticancer agents. Chem Bio Drug Des. 2023;102:357–76. https://doi.org/10.1111/cbdd.14236.

Article  CAS  Google Scholar 

Lee YT, Tan YJ, Oon CE. Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine. Acta Pharm Sin B. 2023;13:478–97. https://doi.org/10.1016/j.apsb.2022.09.010.

Article  CAS  PubMed  Google Scholar 

Lombardi PM, Cole KE, Dowling DP, Christianson DW. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. Curr Opin Struc Biol. 2011;21:735–43. https://doi.org/10.1016/j.sbi.2011.08.004.

Article  CAS  Google Scholar 

Zhang L, Zhang J, Jiang Q, Zhang L, Song W. Zinc binding groups for histone deacetylase inhibitors. J Enzym Inhib Med Chem. 2018;33:714–21. https://doi.org/10.1080/14756366.2017.1417274.

Article  CAS  Google Scholar 

Yang F, Zhao N, Ge D, Chen Y. Next-generation of selective histone deacetylase inhibitors. RSC Adv. 2019;9:19571–83. https://doi.org/10.1039/C9RA02985K.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Curcio A, Rocca R, Alcaro S, Artese A. The Histone Deacetylase Family: structural features and application of combined computational methods. Pharmaceuticals. 2024;17:620 https://doi.org/10.3390/ph17050620.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Li X, Zhao H, Liu M, Du J, Zhang J, et al. Discovery of DNA-targeting HDAC inhibitors with potent antitumor efficacy in vivo that trigger antitumor immunity. J Med Chem. 2022;65:3667–83. https://doi.org/10.1021/acs.jmedchem.1c02225.

Article  CAS  PubMed  Google Scholar 

Krstulović L, Leventić M, Rastija V, Starčević K, Jirouš M, Janić I, et al. Novel 7-chloro-4-aminoquinoline-benzimidazole hybrids as inhibitors of cancer cells growth: synthesis, antiproliferative activity, in silico ADME predictions, and docking. Molecules. 2023;28:540 https://doi.org/10.3390/molecules28020540.

Article